RLY-8161

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid TumorsNCT07584226RLAYPhase 1, Phase 2Recruiting2029-05-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.